Results 61 to 70 of about 1,965 (163)
ABSTRACT Severe COVID‐19 involves hyperinflammation and multiorgan pathology, but consistent gene signatures remain elusive. We aimed to identify consensus transcriptomic signatures and molecular mechanisms in severe COVID‐19. We performed an integrative analysis of 39 studies spanning 11 tissue types, 1551 bulk RNA‐seq samples, and over 2 million ...
Jonathan Peña Avila +31 more
wiley +1 more source
Demographic characteristics of 16 patients with mucopolysaccharidoses.
*Disease classification/severity defined as MPS I—Hurler, Hurler-Scheie, Scheie; MPS II—severe = neuronopathic, attenuated = non-neuronopathic.Demographic characteristics of 16 patients with mucopolysaccharidoses.
Beata Kieć-Wilk (5663302) +6 more
core +1 more source
Background: Mucopolysaccharidosis (MPS) is a class of hereditary metabolic diseases that demonstrate itself by accumulating incompletely degraded glycosaminoglycans (GAGs).
Karolina Wiśniewska +6 more
doaj +1 more source
Racial and Ethnic Disparities in Care for Pediatric Sleep‐Disordered Breathing
Abstract Objective Obstructive sleep disordered breathing is the most common indication for pediatric tonsillectomy in the United States, but there are barriers to specialty care that may contribute to disparities in tonsillectomy use. This study examined the association between race, ethnicity, urban/rural residence, and other factors in access to ...
Colleen C. McLaughlin +8 more
wiley +1 more source
FUNCTIONAL INDEPENDENCE OF PEDIATRIC PATIENTS WITH MUCOPOLYSACCHARIDOSES
Objective: To measure the functional independence to perform activities of daily living of pediatric patients diagnosed with mucopolysaccharidoses. Methods: A descriptive cross-sectional study was carried out with the population of pediatric patients ...
Diógenes Pires Serra Filho (7142108) +2 more
core +1 more source
Abstract Data from a phase 2/3, randomized, controlled, open‐label, multicenter trial in children with neuronopathic mucopolysaccharidosis II (MPS II; Hunter syndrome) older than 3 years suggested a benefit of intrathecal idursulfase‐IT on cognitive functioning in some patients. We describe a separate, parallel, open‐label, single‐arm, 52‐week substudy
Joseph Muenzer +14 more
wiley +1 more source
Early diagnosis of mucopolysaccharidoses in developing countries: A low cost and easy execution approach. [PDF]
Clin Chim Acta. 2017 Feb 28;468:150-151. doi: 10.1016/j.cca.2017.02.020. [Epub ahead of print] Early diagnosis of mucopolysaccharidoses in developing countries: A low cost and easy execution approach.
Monachesi, C +46 more
core +1 more source
Background: Glutaric acidemia (GAI) and mucopolysaccharidosis type IIIB (MPSIIIB) are two rare genetic disorders caused by pathogenic variants in two different genes.
Mohammad Reza Alaei +4 more
doaj
Alkaline Phosphatase and Infantile GM1 Gangliosidosis: A Simple Biomarker for a Complex Disease?
ABSTRACT GM1 gangliosidosis is a lysosomal storage disease (LSD) caused by β‐galactosidase deficiency, characterized by the accumulation of gangliosides in various tissues. Among different GM1 forms (infantile form, late‐infantile and juvenile form, and late‐onset form), the infantile form is the most severe: despite an early clinical onset with rapid ...
Laura Fiori +19 more
wiley +1 more source
Special airway concerns in patients with mucopolysaccharidoses [PDF]
SummaryThe mucopolysaccharidoses are comprised of hereditary disorders joined by errant degradation of mucopolysaccharides. The relatively infrequent opportunity to care for these patients is evidenced by a fairly small number of case reports and ...
Steven Sims, H., Kempiners, James J.
core +1 more source

